Cytosorbents CorpNASDAQ:CTSO
- LAST PRICE3.3500
- TODAY'S CHANGE (%)0.0300 (0.9036%)
- Bid / Lots3.1900/ 1
- Ask / Lots3.5500/ 8
- Open / Previous Close3.3400 / 3.3200
- Day Range
- 52 Week Range
- Volume27,225
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CTSO |
|---|---|---|
| 09:50 ET | 1810 | 3.34 |
| 10:28 ET | 100 | 3.27 |
| 10:57 ET | 775 | 3.24 |
| 11:27 ET | 456 | 3.2806 |
| 11:44 ET | 445 | 3.2851 |
| 11:47 ET | 100 | 3.265 |
| 12:32 ET | 150 | 3.2681 |
| 01:01 ET | 1500 | 3.2647 |
| 01:15 ET | 823 | 3.23 |
| 01:32 ET | 3751 | 3.26 |
| 01:46 ET | 1163 | 3.2722 |
| 02:00 ET | 100 | 3.29 |
| 02:15 ET | 953 | 3.3 |
| 02:20 ET | 2756 | 3.34 |
| 02:22 ET | 100 | 3.3 |
| 02:27 ET | 1802 | 3.3 |
| 03:00 ET | 100 | 3.38 |
| 03:03 ET | 656 | 3.35 |
| 03:05 ET | 100 | 3.37 |
| 03:07 ET | 200 | 3.38 |
| 03:09 ET | 100 | 3.35 |
| 03:12 ET | 100 | 3.37 |
| 03:14 ET | 100 | 3.38 |
| 03:32 ET | 400 | 3.38 |
| 03:34 ET | 100 | 3.37 |
| 03:38 ET | 100 | 3.37 |
| 03:52 ET | 1301 | 3.38 |
| 03:54 ET | 100 | 3.39 |
| 03:56 ET | 100 | 3.37 |
| 03:57 ET | 600 | 3.37 |
| 03:59 ET | 100 | 3.35 |
Today
Mar 14, 2023
BRIEF-Cytosorbents Comments On Bank Exposure And Diversified Cash Position, from 7:15AM ET on Tuesday Mar 14, 2023 by Thomson Reuters
7:15AM ET on Tuesday Mar 14, 2023 by Thomson ReutersCytoSorbents Comments on Bank Exposure and Diversified Cash Position, from 7:00AM ET on Tuesday Mar 14, 2023 by GlobeNewswire
7:00AM ET on Tuesday Mar 14, 2023 by GlobeNewswire
Mar 9, 2023
BRIEF-Cytosorbents Reports Fourth Quarter And Full Year 2022 Results, from 6:16PM ET on Thursday Mar 09, 2023 by Thomson Reuters
6:16PM ET on Thursday Mar 09, 2023 by Thomson ReutersBRIEF-CytoSorbents Reports Fourth Quarter And Full Year 2022 Results, from 4:22PM ET on Thursday Mar 09, 2023 by Thomson Reuters
4:22PM ET on Thursday Mar 09, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cytosorbents Corp | 145.0M | -4.4x | --- |
Stereotaxis Inc | 143.3M | -7.6x | --- |
Co-Diagnostics Inc | 59.1M | -3.1x | --- |
Electromed Inc | 85.7M | 42.5x | -0.05% |
Sensus Healthcare Inc | 86.7M | 3.4x | --- |
Neuropace Inc | 89.4M | -2.0x | --- |
Company Information
CytoSorbents Corporation is a critical care-focused immunotherapy company. The Company is engaged in the treatment of life-threatening conditions in the intensive care (ICU) and cardiac surgery using blood purification via its polymer adsorption technology. The Company's lead product, CytoSorb, is an extracorporeal cytokine absorber, designed to reduce the cytokine storm or cytokine release syndrome that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, cytokine release syndrome due to cancer immunotherapy and pancreatitis. Its other products include animal-targeted VetResQ, DrugSorb-ATR and ECOS-300CY. The Company's product candidates under development includes CytoSorb XL, BetaSorb, ContrastSorb, DrugSorb, HemoDefend-RBC, HemoDefend-BGA, K+ontrol, and others consist of a cartridge containing adsorbent and porous polymer beads.
Contact Information
- Headquarters
- 305 COLLEGE ROAD EASTPRINCETON, NJ, United States 08540
- Phone
- 973-329-8885
- Fax
- ---
Executives
- Independent Non-Executive Chairman of the Board
- Al Kraus
- President, Chief Operating Officer
- Vincent Capponi
- Chief Executive Officer, Director
- Phillip Chan
- Chief Financial Officer
- Kathleen Bloch
- Chief Medical Officer
- Efthymios Deliargyris
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $145.0M |
|---|---|
Revenue (TTM) | $34.7M |
Shares Outstanding | 43.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.74 |
EPS | $-0.75 |
Book Value | $0.81 |
P/E Ratio | -4.4x |
Price/Sales (TTM) | 4.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -90.87% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
